-
Product Insights
NewNet Present Value Model: Eli Lilly and Co’s PR-001
Empower your strategies with our Net Present Value Model: Eli Lilly and Co's PR-001 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ketamine Hydrochloride PR in Treatment Resistant Depression
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ketamine Hydrochloride PR in Treatment Resistant Depression report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ketamine Hydrochloride PR in Treatment Resistant Depression Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PR-15 in Acute Coronary Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PR-15 in Acute Coronary Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PR-15 in Acute Coronary Syndrome Drug Details: PR-15 (revacept, GPVI-Fc) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PR-15 in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PR-15 in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PR-15 in Peripheral Arterial Disease (PAD)/...
-
Product Insights
Likelihood of Approval Analysis for Hormone Sensitive Breast Cancer
Overview How likely is it that the drugs in Hormone Sensitive Breast Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hormone Sensitive Breast Cancer Overview Estrogen and progesterone promote the...
-
Product Insights
NewHernia Repair Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hernia Repair Devices Pipeline Market Report Overview Hernia Repair Device is a hernia mesh used to cure a hernia. Hernia is a condition where an organ or tissue bulges out through a weak spot in the surrounding muscle or connective tissue and can arise in a variety of locations throughout the body, including the pelvis, abdomen, and diaphragm. The hernia repair devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at...
-
Product Insights
NewPulse Oximeter Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Pulse Oximeter Systems Pipeline Market Report Overview A pulse oximeter system is a photoelectric instrument that noninvasively and continuously measures the oxygen saturation of blood. A pulse oximeter consists of the monitor containing the batteries and display, and the probe that senses the pulse. The pulse oximeter systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the...
-
Product Insights
NewNet Present Value Model: AstraZeneca Plc’s PRS-060
Empower your strategies with our Net Present Value Model: AstraZeneca Plc's PRS-060 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BOS-342 in Metastatic Hepatocellular Carcinoma (HCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BOS-342 in Metastatic Hepatocellular Carcinoma (HCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BOS-342 in Metastatic Hepatocellular Carcinoma (HCC) Drug Details: PRS-342...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BOS-342 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BOS-342 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BOS-342 in Solid Tumor Drug Details: PRS-342 is under development for...